UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report...
Day: August 27, 2021
Sorrento Reports Promising Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device
Sorrento’s mRNA vaccine (“STI-mRNA”) delivered with the MuVaxx™ Lymphatic Drug Delivery Device (“MuVaxx”), at 1/10th of the dose vs an...
MDxHealth Reports Half Year 2021 Results
NEWS RELEASE - REGULATED INFORMATION26 AUGUST 2021, 18:00 CET MDxHealth Reports Half Year 2021 Results Conference call with Q&A today...
OSE Immunotherapeutics and ARCAGY-GINECO Announce First Patient Randomized in Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Pembrolizumab in Ovarian Cancer
Clinical trial sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp & Dohme Corp....
Financial incentives to enhance participation of resident physicians in quality improvement projects
Study in September2021 issue ofThe Joint Commission Journal on Quality and Patient SafetyOAKBROOK TERRACE, Ill., Aug. 26, 2021 (GLOBE NEWSWIRE)...
Denali Therapeutics Announces Publication in Cell on New Approach to Treat FTD-GRN
Preclinical studies show enhanced brain uptake of progranulin can be achieved using Denali’s Transport Vehicle to cross the blood-brain barrierSOUTH...
Innovative MedTech Announces Subsidiary SarahCare Renews Agreements for Adult Day Care Franchises in Texas
Franchise Renewals Mean Continued Delivery of Necessary Day Services to Older Adults and VeteransBLUE ISLAND, Ill., Aug. 26, 2021 (GLOBE...
The Newly Institute Closes its Over-Subscribed Seed Round to Bring Revolutionary Mental Health Treatment to Canada
Clinics are currently being built in Calgary, Fredericton and Edmonton. The Newly continues to finalize locations in other Canadian cities,...
AlzeCure’s ACD856 Demonstrates Good Tolerability in Phase I Clinical Trial and is Approved for Additional Doses
STOCKHOLM, SWEDEN / ACCESSWIRE / August 27, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...